Stocks and Investing Stocks and Investing
Mon, July 11, 2022
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Decreased Target to $41 on, Jul 11th, 2022
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $44 on, Jul 11th, 2022
[ 12:00 AM ] - WOPRAI
Michael Genovese Maintained (ADTN) at Strong Buy with Increased Target to $28 on, Jul 11th, 2022
[ 12:00 AM ] - WOPRAI
Jimmy Bhullar Maintained (AFL) at Hold with Increased Target to $62 on, Jul 11th, 2022
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (ACIU) at Buy with Decreased Target to $10 on, Jul 11th, 2022
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (ACAD) at Buy with Decreased Target to $27 on, Jul 11th, 2022
Sun, July 10, 2022
[ 12:00 AM ] - WOPRAI
Brian White Maintained (AAPL) at Strong Buy and Held Target at $174 on, Jul 10th, 2022
Fri, July 8, 2022
[ 12:00 AM ] - WOPRAI
Connie Gu Maintained (BABA) at Strong Buy with Increased Target to $162 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Sophie Huang Maintained (BABA) at Strong Buy and Held Target at $151 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $54 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (AZPN) at Buy with Increased Target to $210 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Biegler Initiated (BPMC) at Buy and Held Target at $80 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Laura Champine Maintained (BURL) at Strong Sell with Decreased Target to $120 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Parkhill Maintained (CAG) at Hold with Increased Target to $35 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (CARR) at Buy with Decreased Target to $47 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Patrick Donnelly Maintained (BIO) at Strong Buy with Decreased Target to $700 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Shweta Khajuria Maintained (BMBL) at Buy with Increased Target to $38 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Ken Worthington Maintained (BLK) at Buy with Decreased Target to $729 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Chris Lucas Initiated (AMH) at Buy and Held Target at $43 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (ALLE) at Buy with Decreased Target to $125 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
John Barnidge Maintained (AMP) at Sell with Decreased Target to $231 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Lisa Gill Maintained (WBA) at Hold with Decreased Target to $45 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Eric Luebchow Maintained (VZ) at Hold with Decreased Target to $52 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Linda Bolton Weiser Maintained (WDFC) at Hold with Decreased Target to $169 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
RJ Milligan Maintained (WPC) at Buy with Increased Target to $95 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Garik Shmois Maintained (WMS) at Strong Buy with Decreased Target to $124 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
John Staszak Downgraded (AAL) to Hold on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Patrick Donnelly Downgraded (A) to Hold and Decreased Target to $140 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Cesar Medina Downgraded (ZENV) to Hold and Decreased Target to $4 on, Jul 8th, 2022
[ 12:00 AM ] - WOPRAI
Robert Driscoll Initiated (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022

Robert Driscoll Initiated (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022


Published on 2024-10-27 21:48:43 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Initiated "Aprea Therapeutics, Inc." (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022.

Robert has made no other calls on APRE in the last 4 months.



There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, all agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Andrew Fein of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $40 on, Wednesday, March 16th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $80 on, Wednesday, March 16th, 2022
Contributing Sources